<DOC>
	<DOC>NCT00669123</DOC>
	<brief_summary>The purpouse of this study is to determine the efficacy and safety of chondroitin sulphate conventional treatment in patients with both knee osteoarthritis and plaque psoriasis.</brief_summary>
	<brief_title>Chondroitin Sulphate Efficay/Safety in Patients With Knee Osteoarthritis and Psoriasis</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Psoriasis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<mesh_term>Joint Diseases</mesh_term>
	<mesh_term>Skin Diseases</mesh_term>
	<criteria>Primary knee OA according to ACR criteria; OA of radiological stages 1 to 3 according to KellgrenLawrence; VAS of pain ≥30; PASI ≥ 5. Known allergy to chondroitin sulphate; Other bone and articular diseases such as chondrocalcinosis, Paget's disease, rheumatoid arthritis, psoriatic arthritis, acromegaly, hemochromatosis, Wilson's disease; Patients with skin conditions that could interfere in the clinical trial evaluation</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2008</verification_date>
	<keyword>Chondroitin sulphate</keyword>
	<keyword>Knee osteoarthritis</keyword>
	<keyword>Psoriasis</keyword>
</DOC>